ESC 365 - Influence of long-lasting treatment with ramipril and eprosartan on diastolic dysfunction and insulin resistance

HFA Premium Access

Influence of long-lasting treatment with ramipril and eprosartan on diastolic dysfunction and insulin resistance

Session: Poster session 3 - Renin-angiotensin-aldosterone antagonists

Topic: Renin-angiotensin-aldosterone antagonists

Speaker: Doctor N. Sapojnic (Chisinau, MD)

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Congress Presentation

About the speaker

Doctor Nadejda Sapojnic

Polivalent Hospital Novamed, Chisinau (Moldova (Republic of))

0 follower

2 more presentations in this session

Effect of renin-angiotensin antagonist in patients with impaired renal function and heart failure: results from KorAHF registry

Speaker: Assistant Professor S. Jang (Daegu, KR)

Real world experience of introducing the new heart failure drug LCZ 696 in ambulatory care setting

Speaker: Ms L. O'connor (Dublin, IE)

Access the full session

Poster session 3 - Renin-angiotensin-aldosterone antagonists

Speakers: Doctor N. Sapojnic, Assistant Professor S. Jang, Ms L. O'connor

About the event

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April - 2 May 2017

Sessions Presentations

Congress

ESC 365 is supported by